TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE).

Rana R McKay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.